Established in 1990, Mika Medical’s needle free injection system is suitable for people who fear needle pain and diabetic patients in need of frequent insulin administration. Micro-sized holes on the surface of the nozzles, strong spring pressure, and a high-velocity jets of medication, allow medication to penetrate into the human body without causing any pains by removing the conventional needles.
Comfort-in does not alter the efficacy of the drug compared to regular needle injections, with some studies showing the technology to actually increased efficacy. This is good news for children who are afraid of needles and diabetics who suffer skin damage caused by frequent needle injections.
Mika Medical has donated “pain-free self-injection needle free” for young diabetic patients through the Korea Evaluation Institute of Industrial Technology (KEIT). Comfort-in was delivered to 25 children, demonstrating its commitment to helping people lead a better life.
After launching development and production of needle free injection in 2013, Mika Medical has taken the spotlight in Korea. A global company with agents in Europe, South America, Asia, the Middle East, and Africa, Mika has a rich history of participating in exhibitions around the world, and holds domestic and international patent technology and design registration certificates.
Based on the company�s motto of promoting a healthy life, they look forward to further progress by Mika Medical, which is pushing forward with growth and expansion in the domestic and international medical markets.
Let’s block ads! (Why?)
New slot tournament, Blackjack Quest and poker event here this month SYDNEY--(BUSINESS WIRE)--A new month…
AUBURN HILLS, Mich.--(BUSINESS WIRE)--#safety--Teijin Automotive Technologies held a ribbon cutting today to celebrate the opening…
VANCOUVER--(BUSINESS WIRE)--Capstone Copper Corp. (“Capstone” or the “Company”) (TSX:CS) (ASX:CSC) announced the voting results from…
DUBLIN--(BUSINESS WIRE)--The "Indonesia International Remittance Market Business and Investment Opportunities - Analysis by Transaction Value…
KCAS Bio continues to expand its global reach and has selected Crux Biolabs (Melbourne, Australia)…
Strengthens end-to-end RCM offering to healthcare providers Expands service capabilities to US physicians’ practices, and…